Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Potassium

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 73Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    FDA Grants ODE for Xywav Oral Solution for Idiopathic Hypersomnia in Adults
    FDA Grants ODE for Xywav Oral Solution for Idiopathic Hypersomnia in Adults

    03 Jan 2022

    // BIOSPACE

    https://www.biospace.com/article/releases/u-s-fda-grants-orphan-drug-exclusivity-ode-for-xywav-calcium-magnesium-potassium-and-sodium-oxybates-oral-solution-for-idiopathic-hypersomnia-in-adults/

    BIOSPACE
    03 Jan 2022
    Share Share
    Jazz Pharmaceuticals Announces SLEEP Publication of Phase 3 Xywav™
    Jazz Pharmaceuticals Announces SLEEP Publication of Phase 3 Xywav™

    20 Oct 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-announces-sleep-publication-of-phase-3-xywav-calcium-magnesium-potassium-and-sodium-oxybates-oral-solution-study-in-cataplexy-or-excessive-daytime-sleepiness-in-patients-with-narcolepsy-301155706.html

    PRNEWSWIRE
    20 Oct 2020
    Share Share
    Jazz Pharms` Xywav (Calcium;Magnesium:Potassium ) Receives Approval in Europe
    Jazz Pharms` Xywav (Calcium;Magnesium:Potassium ) Receives Approval in Europe

    25 Jul 2020

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212690

    FDA
    25 Jul 2020
    Share Share
    Enforcement Report - Week of March 25, 2020
    Enforcement Report - Week of March 25, 2020

    25 Mar 2020

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-25-2020-1585131468.pdf

    FDA
    25 Mar 2020
    Share Share
    Granules received US FDA approval for Potassium Chloride ER Tablets USP
    Granules received US FDA approval for Potassium Chloride ER Tablets USP

    03 Mar 2020

    // Vinayak Gangule PRESS RELEASE

    https://www.equitybulls.com/admin/news2006/news_det.asp?id=263937

    Vinayak Gangule PRESS RELEASE
    03 Mar 2020
    Share Share
    AZ potassium drug finally approved, threatening Vifor
    AZ potassium drug finally approved, threatening Vifor

    22 May 2018

    // Ben Hirschler REUTERS

    https://www.reuters.com/article/us-astrazeneca-launch/astrazeneca-potassium-drug-finally-approved-threatening-vifor-idUSKCN1IM13F

    Ben Hirschler REUTERS
    22 May 2018
    Share Share